InvestorsHub Logo
Followers 1
Posts 1178
Boards Moderated 0
Alias Born 02/01/2013

Re: None

Friday, 03/16/2018 10:30:05 AM

Friday, March 16, 2018 10:30:05 AM

Post# of 108192
AACR 2018 late breaking abstract Amgen/advaxis
LB-150 / 17 - Neoantigens that fail to elicit measurable T cell responses following peptide immunization can control tumor growth when delivered using a Listeria-based immunotherapy platform

http://www.abstractsonline.com/pp8/#!/4562/presentation/10472
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News